LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 84.10 | 56.33 | 3933 | 7655 | 0.5165 | 0.6606 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 85.80 | 56.33 | 4024 | 7583 | 0.5325 | 0.6802 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.50 | 56.33 | 4042 | 7334 | 0.5515 | 0.6812 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 89.20 | 56.33 | 4032 | 7229 | 0.5573 | 0.6799 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 90.90 | 56.33 | 4007 | 7174 | 0.5577 | 0.6651 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 92.60 | 56.33 | 4061 | 7065 | 0.5740 | 0.6684 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 94.30 | 56.33 | 4092 | 6924 | 0.5905 | 0.6557 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 95.70 | 27.76 | 3718 | 6712 | 0.5539 | 0.6820 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 2.30 | 56.33 | 268 | 255 | 1.0491 | 0.5237 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 4.00 | 56.33 | 306 | 303 | 1.0085 | 0.4935 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.70 | 56.33 | 348 | 342 | 1.0141 | 0.4795 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.40 | 56.33 | 392 | 385 | 1.0163 | 0.5181 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 9.10 | 56.33 | 427 | 424 | 1.0060 | 0.5251 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.80 | 56.33 | 458 | 465 | 0.9852 | 0.5892 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.50 | 56.33 | 521 | 510 | 1.0225 | 0.6942 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.20 | 56.33 | 659 | 634 | 1.0422 | 0.7818 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 15.90 | 56.33 | 716 | 726 | 0.9870 | 0.7894 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 17.60 | 56.33 | 809 | 868 | 0.9325 | 0.8405 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 19.30 | 56.33 | 877 | 1090 | 0.8152 | 0.8029 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 21.00 | 56.33 | 983 | 1286 | 0.7800 | 0.8149 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 22.80 | 56.33 | 1065 | 1460 | 0.7406 | 0.8110 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 24.50 | 56.33 | 1121 | 1615 | 0.7035 | 0.7979 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 26.20 | 56.33 | 1189 | 1764 | 0.6822 | 0.7903 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.90 | 56.33 | 1236 | 1907 | 0.6567 | 0.7892 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 29.60 | 56.33 | 1320 | 2050 | 0.6518 | 0.7908 |